Platelet Transfusion: Indications, Patient Groups, and Clinical Use

Platelet transfusions are indicated for thrombocytopenia or platelet dysfunction with bleeding risk.

Key Patient Groups

  1. Thrombocytopenia: Chemotherapy, marrow failure, DIC, sepsis, drug-induced (heparin, quinine). Transfuse if <10×10⁹/L (prophylactic) or <50×10⁹/L (active bleeding/surgery).
  2. Immune thrombocytopenia (ITP): Autoantibodies destroy platelets. Transfuse for severe bleeding; otherwise steroids/IVIG/TPO-RAs first.
  3. Hematologic malignancies (leukemia, lymphoma): Disease + chemo → thrombocytopenia. Frequent transfusions during induction.
  4. Massive hemorrhage: Trauma, surgery, PPH – part of massive transfusion protocol (1:1:1 RBC:plasma:platelets).
  5. Inherited platelet disorders: Glanzmann thrombasthenia, Bernard-Soulier, Wiskott-Aldrich – transfuse for bleeding/procedures.
  6. Post-transplant (HSCT/solid organ): Conditioning regimen causes thrombocytopenia; support until engraftment.
  7. Pediatrics: Neonatal alloimmune thrombocytopenia (NAIT), chemotherapy, congenital disorders.

Product

Apheresis (single donor) or pooled whole-blood derived; leukoreduced, irradiated if needed. ABO-compatible preferred.

Blood Disorders - Related Articles